An overview of video games
Video games provide an exciting, interactive experience with a user interface that generates visual feedback on a video devices such as a computer monitor or a TV screen. The display device can produc...
Read MoreNivolumab drug is a fully humanized, monoclonal, immunoglobulin antibody, with which clinical trials are being undertaken for the treatment of various types of cancer. Each Nivolumab clinical trial is conducted by the US National Institute of Health and is supported by the government to help find answers to cancer treatment.
Each trial targets a particular group of candidates to study the actual impact of the drug on that particular type of cancer. Thus, the eligibility criteria for each Nivolumab clinical trial may differ. However, some of the common aspects to choose the right candidate for the trial are as follows:
Apart from all the above, it is usually also required that the candidate should not have had any anticancer chemotherapy within four weeks before the administration of the study drug.
Subscribe to our weekly newsletter for the latest updates